FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on June 24, 2020 include: Coronavirus (COVID-19) Updates:- June 30, 2020: Daily Roundup: FDA actions on topics including a vaccine guidance, new FDA Insight podcast, new EUA, and a testing update
- June 30, 2020: Update on Progress Toward Safely Getting Back to Work and Back to School - testimony from FDA Commissioner Stephen M. Hahn, MD and other HHS officials
- June 30, 2020: FDA Takes Action to Help Ensure Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- June 25, 2020: FDA Voices: Partnering with the European Union and Global Regulators on COVID-19
- June 24, 2020: Joint Statement from USDA and FDA on Food Export Restrictions Pertaining to COVID-19
- June 23, 2020: FDA Holds Meetings with the European Commission (EC) and the European Medicines Agency (EMA) to Strengthen Medical Products Cooperation
- Also see the features and Emergency Use Authorization Updates below
|
|
|
|
No hay comentarios:
Publicar un comentario